Curated News:

Medical Meetings

Add to Favorites Subscribe Share
fbshare-Medical Meetings

Showing results

110 of 3955
Newswise: Yale Cancer Center researchers investigate inducing “synthetic lethality” in two blood and bone cancers

Yale Cancer Center researchers investigate inducing “synthetic lethality” in two blood and bone cancers

Yale Cancer Center

In a clinical trial led by Yale Cancer Center (YCC) and Smilow Cancer Hospital, researchers aim to exploit DNA mutations in the treatment of two blood and bone marrow cancers, a different tacit than the more traditional approach of blunting or switching off genetic mutations linked to cancer

Channels: All Journal News, Blood, Cancer, Genetics, Healthcare, Medical Meetings,

Released:
10-Dec-2019 10:55 AM EST
ACR-Logo-2019 .jpg

Complimentary Press Registration Available for the 2020 Winter Rheumatology Symposium

American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) welcomes members of the press to write about rheumatology research presented at the Winter Rheumatology Symposium in Snowmass Village, CO on January 25 -31, 2020.

Channels: Arthritis, Bone Health, Medical Meetings,

Released:
10-Dec-2019 9:00 AM EST
Research Results
Newswise: ASH: Research revises classification of acute myeloid leukemia and myelodysplastic syndrome

ASH: Research revises classification of acute myeloid leukemia and myelodysplastic syndrome

St. Jude Children's Research Hospital

Results from a study conducted by St. Jude Children’s Research Hospital and the Munich Leukemia Laboratory were presented today as a late-breaking abstract at the American Society of Hematology annual meeting. The study integrates genomic and transcriptomic sequencing to provide the most detailed classification of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) to date.

Channels: Blood, Cancer, Cell Biology, Medical Meetings,

Released:
10-Dec-2019 8:15 AM EST
Feature
Research Results
mmc-logo.gif
  • Embargo expired:
    9-Dec-2019 6:00 PM EST

New Mayo Clinic studies to be presented at American Society of Hematology meeting

Mayo Clinic

Mayo Clinic researchers will present findings at the American Society of Hematology Annual Meeting Dec. 7–10 in Orlando. New Mayo Clinic studies to be presented include: DNA analysis identifies elevated risk factor for myeloma in individuals of African ancestry Study identifies more precise assessment measures for patients newly diagnosed with chronic lymphocytic leukemia Researchers develop method to assess cancer-fighting cell therapy's effectiveness

Channels: All Journal News, Blood, Cancer, Stem Cells, Medical Meetings,

Released:
6-Dec-2019 10:10 AM EST
Research Results
Newswise: Small Mutations Identified through Deep DNA Sequencing for AML and MDS

Small Mutations Identified through Deep DNA Sequencing for AML and MDS

Rutgers Cancer Institute of New Jersey

Deep DNA sequencing analysis conducted by Rutgers Cancer Institute of New Jersey investigators examining genomic differences within tumors for prediction of disease relapse in certain hematologic malignancies has identified small mutations. These may help further guide treatment decision making for patients.

Channels: All Journal News, Blood, Cancer, Genetics, Medical Meetings,

Released:
9-Dec-2019 5:05 PM EST
Research Results
Newswise: Retrospective Analysis Shows Proton Therapy Well Tolerated in Patients Undergoing Breast Conserving Surgery

Retrospective Analysis Shows Proton Therapy Well Tolerated in Patients Undergoing Breast Conserving Surgery

Rutgers Cancer Institute of New Jersey

Investigators at Rutgers Cancer Institute of New Jersey conducted a retrospective review of patients treated with proton therapy following breast-conserving surgery and found acceptable toxicity rates along with good-to-excellent patient-reported cosmetic outcomes.

Channels: All Journal News, Cancer, Healthcare, Surgery, Women's Health, Medical Meetings,

Released:
9-Dec-2019 4:20 PM EST
Research Results
Newswise: Yale Cancer Center study suggests new approaches needed to manage ibrutinib-related toxicities in CLL patients
  • Embargo expired:
    9-Dec-2019 3:45 PM EST

Yale Cancer Center study suggests new approaches needed to manage ibrutinib-related toxicities in CLL patients

Yale Cancer Center

New findings by Yale Cancer Center (YCC) and Smilow Cancer Hospital researchers show that as the use of the drug ibrutinib climbs in patients with chronic lymphocytic leukemia (CLL), so do the rates of patients who stop taking the drug.

Channels: All Journal News, Blood, Cancer, Clinical Trials, Pharmaceuticals, Medical Meetings,

Released:
9-Dec-2019 10:50 AM EST
Research Results
Newswise: Yale Cancer Center researchers show promising new treatment for patients with myelodysplastic syndromes

Yale Cancer Center researchers show promising new treatment for patients with myelodysplastic syndromes

Yale Cancer Center

A new study by Yale Cancer Center (YCC) and Smilow Cancer Hospital researchers suggests that the drug venetoclax aids therapy for relapsed/refractory myelodysplastic syndromes, especially when paired with azacytidine.

Channels: All Journal News, Blood, Cancer, Pharmaceuticals, Healthcare, Medical Meetings,

Released:
9-Dec-2019 11:05 AM EST
Research Results
Newswise: AAO and ASCRS Launch Ophthovation™ Joint Venture to Deliver Next Generation of Business Innovation Conferences

AAO and ASCRS Launch Ophthovation™ Joint Venture to Deliver Next Generation of Business Innovation Conferences

American Academy of Ophthalmology (AAO)

Two of the world’s largest ophthalmic organizations have finalized their joint venture Ophthovation™ to develop business conferences that accelerate innovation in ophthalmology called the Ophthovation™ Conference.

Channels: Entrepreneurship, Vision, Medical Meetings,

Released:
9-Dec-2019 11:00 AM EST
Research Results

Showing results

110 of 3955

Chat now!
18.49849